These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6779061)

  • 21. Mucopolysaccharidosis type I: clinical and biochemical study.
    Bassyouni HT; Afifi HH; el-Awadi MK; Meguid NA
    East Mediterr Health J; 2000; 6(2-3):359-66. PubMed ID: 11556024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Properties of alpha-L-iduronidase in cultured skin fibroblasts from alpha-L-iduronidase-deficient patients.
    Fujibayashi S; Minami R; Ishikawa Y; Wagatsuma K; Nakao T; Tsugawa S
    Hum Genet; 1984; 65(3):268-72. PubMed ID: 6421718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative ERGs in mucopolysaccharidoses (MPS) Hurler-Scheie (I-H/S) and Hurler (I-H)-syndromes.
    Tzetzi D; Hamilton R; Robinson PH; Dutton GN
    Doc Ophthalmol; 2007 May; 114(3):153-8. PubMed ID: 17464575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: In-vitro confirmation of genetic compound of the Hurler and Scheie syndromes.
    Danes BS
    Lancet; 1974 Apr; 1(7859):680. PubMed ID: 4132345
    [No Abstract]   [Full Text] [Related]  

  • 25. Further electroretinographic studies of patients with mucopolysaccharidoses.
    Leung LS; Weinstein GW; Hobson RR
    Birth Defects Orig Artic Ser; 1971 Mar; 7(3):32-40. PubMed ID: 5006141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conjunctival ultrastructure in mucolipidosis 3 (pseudo-Hurler polydystrophy).
    Quigley HA; Goldberg MF
    Invest Ophthalmol; 1971 Aug; 10(8):568-80. PubMed ID: 4255138
    [No Abstract]   [Full Text] [Related]  

  • 27. Biochemical discrimination of Hurler and Scheie syndromes.
    Hopwood JJ; Muller V
    Clin Sci (Lond); 1979 Sep; 57(3):265-72. PubMed ID: 38945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variant of iduronidase deficient mucopolysaccharidoses: further evidence for genetic heterogeneity.
    Danes BS
    J Med Genet; 1977 Oct; 14(5):346-51. PubMed ID: 412969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucopolysaccharidoses and mucolipidoses.
    Van Hoof F
    J Clin Pathol Suppl (R Coll Pathol); 1974; 8():64-93. PubMed ID: 4220223
    [No Abstract]   [Full Text] [Related]  

  • 30. Schei's syndrome: report in two siblings.
    Soodan VM; Goel RK
    Indian Pediatr; 1976 Dec; 13(12):949-52. PubMed ID: 828902
    [No Abstract]   [Full Text] [Related]  

  • 31. Ocular manifestations of Hurler/Scheie phenotype in two sibs.
    Chijiiwa T; Inomata H; Yamana Y; Kaibara N
    Jpn J Ophthalmol; 1983; 27(1):54-62. PubMed ID: 6406726
    [No Abstract]   [Full Text] [Related]  

  • 32. Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republic.
    Murphy AM; Lambert D; Treacy EP; O'Meara A; Lynch SA
    Arch Dis Child; 2009 Jan; 94(1):52-4. PubMed ID: 18463126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorimetric assay for prenatal detection of Hurler and Scheie homozygotes or heterozygotes.
    Stirling JL; Robinson D; Fensom AH; Benson PF; Baker JE
    Lancet; 1978 Jan; 1(8056):147. PubMed ID: 87574
    [No Abstract]   [Full Text] [Related]  

  • 34. alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
    Hein LK; Bawden M; Muller VJ; Sillence D; Hopwood JJ; Brooks DA
    J Mol Biol; 2004 Apr; 338(3):453-62. PubMed ID: 15081804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Possible genetic nature of phenotypical differences of mucopolysaccharidosis 1].
    Kobrinskiĭ BA
    Vopr Med Khim; 1982; 28(3):55-7. PubMed ID: 6808766
    [No Abstract]   [Full Text] [Related]  

  • 36. alpha-L-iduronidase deficiency and possible Hurler-Scheie genetic compound. Clinical, pathologic, and biochemical findings.
    Winters PR; Harrod MJ; Molenich-Heetred SA; Kirkpatrick J; Rosenberg RN
    Neurology; 1976 Nov; 26(11):1003-7. PubMed ID: 824566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mucopolysaccharidosis type I in the Cuban population].
    Menéndez-Sainz C; Zaldívar-Muñoz C; González-Quevedo A
    Rev Neurol; 2003 Sep 16-30; 37(6):525-8. PubMed ID: 14533069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hurler-Scheie compound-a variant of MPS-i (MPS-i H/S) (A case report).
    Bhandari B; Ranka SL
    Indian Pediatr; 1980 Dec; 17(12):971-3. PubMed ID: 6788695
    [No Abstract]   [Full Text] [Related]  

  • 39. Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations.
    Beesley CE; Meaney CA; Greenland G; Adams V; Vellodi A; Young EP; Winchester BG
    Hum Genet; 2001 Nov; 109(5):503-11. PubMed ID: 11735025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrafamilial variability in Hurler syndrome and Sanfilippo syndrome type A: implications for evaluation of new therapies.
    McDowell GA; Cowan TM; Blitzer MG; Greene CL
    Am J Med Genet; 1993 Nov; 47(7):1092-5. PubMed ID: 7507293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.